Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients

COVID-19 vaccination is recommended for multiple sclerosis patients. Disease-modifying therapies can influence the safety and efficacy of COVID-19 vaccines. RNA, DNA, protein, and inactivated vaccines are likely safe for multiple sclerosis patients. A few incidences of central demyelination were rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Hannah, Sokola, Brent, Abboud, Hesham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095041/
https://www.ncbi.nlm.nih.gov/pubmed/34000472
http://dx.doi.org/10.1016/j.jneuroim.2021.577599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095041/
https://www.ncbi.nlm.nih.gov/pubmed/34000472
http://dx.doi.org/10.1016/j.jneuroim.2021.577599

Ejemplares similares